Sort
64,565 grants matching “drug discovery”
Discovery of Pharmacogenomic Biomarkers for OATP1B1 and OATP1B3
$624,418Kathleen M Giacomini · University Of California, San Francisco · R01 · FY2020 · GM
Development of Drugs Acting at Adenosine Receptors
$624,412Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2019 · DK
WASHINGTON UNIVERSITY CO-CLINICAL IMAGING RESEARCH RESOURCE
$624,395Kooresh Isaac Shoghi · Washington University · U24 · FY2021 · CA
α9α10 Nicotinic Acetylcholine Receptors in neuropathic pain
$624,360Andrew Riley · University Of Illinois At Chicago · R01 · FY2025 · NS
α9α10 Nicotinic Acetylcholine Receptors in neuropathic pain
$624,360Andrew Riley · University Of Illinois At Chicago · R01 · FY2024 · NS
Macrophage Depletion Therapy for Spinal Cord Injury
$624,342John C Gensel · University Of Kentucky · R01 · FY2022 · NS
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program
$624,326Kim L Brouwer · Univ Of North Carolina Chapel Hill · T32 · FY2017 · GM
Development of p300/CBP histone acetyltransferase inhibitors for oncogene-driven cancers
$624,299William C Hahn · Broad Institute, Inc. · R01 · FY2024 · CA
Breaching the Gram negative bacterial cellular envelope
$624,267Yinan Wei · Texas A&M University Health Science Ctr · R01 · FY2025 · AI
Dysregulation of Histone Acetylation in Parkinson's Disease
$624,231Frank Soldner · Albert Einstein College Of Medicine · R56 · FY2023 · NS
Structures of Mtb proteins conferring susceptibility to known Mtb inhibitors
$624,230James C Sacchettini · Texas A&M University · U01 · FY2011 · GM
Molecular Genetics of HSV DNA Polymerase Gene
$624,224Donald M Coen · Harvard Medical School · R56 · FY2017 · AI
Drug Development for Prostate Cancer and other Metastatic Processes
$624,197William Douglas Figg · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Risk Prediction for ER Negative Breast Cancer Recurrence
$624,192Melissa L Bondy · Baylor College Of Medicine · R01 · FY2015 · CA
Preclinical Assays of Hippocampal-Prefrontal Cortical Circuit Engagement for Application in Therapeutic Development
$624,149Andrew Porter Maurer · University Of Florida · R01 · FY2023 · MH
PLEKHA7 A Novel Target for Mutant KRAS Therapy
$624,131Garth Powis · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2017 · CA
PLEKHA7 A Novel Target for Mutant KRAS Therapy
$624,131Garth Powis · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2018 · CA
PLEKHA7 A Novel Target for Mutant KRAS Therapy
$624,131Garth Powis · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2016 · CA
PLEKHA7 A Novel Target for Mutant KRAS Therapy
$624,131Garth Powis · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2015 · CA
Mimicking synuclein toxicity in plant cells to identify novel neuroprotective leads
$624,004John M Littleton · Naprogenix, Inc · R44 · FY2020 · NS
Cannabinoid CB2 Receptor Structure and Allosteric Modulators
$623,964Xiang-Qun Xie · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · DA
2024 SenNet CODCC Supplement
$623,959Jonathan C. Silverstein · University Of Pittsburgh At Pittsburgh · U24 · FY2024 · CA
High Throughput Screening for Pharmacoperones of the V2 Receptor
$623,890Jo Ann Janovick · Texas Tech University Health Scis Center · R01 · FY2015 · DK
PRETARGETING WITH ANTI-CEA MABS FOR THERAPY
$623,885Paul Yazaki · Beckman Research Institute/City Of Hope · P01 · FY2008 · CA
NEW APPROACHES TO TARGET SPECIFIC ANTIFUNGAL AGENTS
$623,834Georgetown University · R01 · FY2000 · CA